Clinical Infectious Diseases | May 20, 2021

Ogata AF, Cheng CA, Desjardins M, Senussi Y, Sherman AC, Powell M, Novack L, Von S, Li X, Baden LR and Walt DR

Clinical Infectious Diseases, ciab465

DOI:  https://doi.org/10.1093/cid/ciab465

This study was performed using Simoa® Homebrew assays.

Abstract

SARS-CoV-2 proteins were measured in longitudinal plasma samples collected from 13 participants who received two doses of mRNA-1273 vaccine. 11 of 13 participants showed detectable levels of SARS-CoV-2 protein as early as day one after first vaccine injection. Clearance of detectable SARS-CoV-2 protein correlated with production of IgG and IgA.